Medigen Vaccine Biologics Corporation (TPEX:6547)

Medigen Vaccine Biologics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,298	11,851	23,035	22,785	63,653	21,743
Market Cap Growth	5.22%	-48.55%	1.10%	-64.20%	192.75%	388.97%
Enterprise Value	11,923	10,382	21,271	20,540	62,660	22,145
Last Close Price	40.45	36.05	70.10	69.50	200.91	69.21
PE Ratio	-	-	-	-	45.14	-
PS Ratio	22.35	19.57	59.12	62.42	19.40	1889.56
PB Ratio	3.69	3.08	5.99	4.53	13.61	6.92
P/TBV Ratio	3.71	3.10	6.05	4.57	13.77	7.06
P/FCF Ratio	-	1835.64	-	-	142.64	-
P/OCF Ratio	554.03	290.80	-	-	109.77	-
EV/Sales Ratio	20.04	17.14	54.59	56.27	19.10	1924.50
EV/EBITDA Ratio	-	-	-	-	58.45	-
EV/EBIT Ratio	-	-	-	-	65.02	-
EV/FCF Ratio	-421.51	1608.05	-	-	140.41	-
Debt / Equity Ratio	0.08	0.09	0.51	0.39	0.04	0.06
Debt / EBITDA Ratio	-	-	-	-	0.17	-
Debt / FCF Ratio	-	52.50	-	-	0.42	-
Asset Turnover	0.14	0.12	0.06	0.06	0.75	0.00
Inventory Turnover	0.58	0.50	0.25	0.76	2.84	0.09
Quick Ratio	10.98	9.54	1.99	12.48	6.54	11.58
Current Ratio	14.12	11.94	2.21	15.38	8.48	12.48
Return on Equity (ROE)	-4.44%	-2.09%	-26.14%	-30.39%	36.08%	-29.91%
Return on Assets (ROA)	-2.50%	-1.74%	-11.29%	-15.18%	13.71%	-16.55%
Return on Capital (ROIC)	-2.60%	-1.82%	-11.85%	-16.21%	14.71%	-17.38%
Return on Capital Employed (ROCE)	-4.30%	-3.50%	-29.60%	-22.00%	19.80%	-22.90%
Earnings Yield	-1.25%	-0.68%	-5.04%	-6.47%	2.22%	-3.10%
FCF Yield	-0.21%	0.05%	-2.26%	-5.94%	0.70%	-3.17%
Buyback Yield / Dilution	-0.01%	-0.10%	-1.50%	-0.73%	-15.82%	-20.08%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.